Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.Boll Chim Farm. 2002 Jan-Feb; 141(1):3-7.BC
Abstract
New N-(5-methylisoxazol-3-yl)-2 or 3 or 4-(phenoxyacetamido)benzamides 6a-t were synthesized and tested for their in vitro antimicrobial activity against gram positive (Staphylococcus aureus ATCC 25923) and gram negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria as well as fungi (Candida albicans ATCC 10231, Candida tropicalis ATCC 13803 and Cryptococcus neoformans ATCC 90112). Compounds 6 were devoid of antibacterial as well as antifungal activities at maximum tested concentrations of 50 micrograms/ml for bacteria and 100 micrograms/ml for yeast.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
12064055
Citation
Raffa, D, et al. "Synthesis and Antimicrobial Evaluation of New Phenoxyacetamide Derivatives." Bollettino Chimico Farmaceutico, vol. 141, no. 1, 2002, pp. 3-7.
Raffa D, Migliara O, Daidone G, et al. Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives. Boll Chim Farm. 2002;141(1):3-7.
Raffa, D., Migliara, O., Daidone, G., Maggio, B., & Schillaci, D. (2002). Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives. Bollettino Chimico Farmaceutico, 141(1), 3-7.
Raffa D, et al. Synthesis and Antimicrobial Evaluation of New Phenoxyacetamide Derivatives. Boll Chim Farm. 2002 Jan-Feb;141(1):3-7. PubMed PMID: 12064055.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.
AU - Raffa,D,
AU - Migliara,O,
AU - Daidone,G,
AU - Maggio,B,
AU - Schillaci,D,
PY - 2002/6/18/pubmed
PY - 2002/7/18/medline
PY - 2002/6/18/entrez
SP - 3
EP - 7
JF - Bollettino chimico farmaceutico
JO - Boll Chim Farm
VL - 141
IS - 1
N2 - New N-(5-methylisoxazol-3-yl)-2 or 3 or 4-(phenoxyacetamido)benzamides 6a-t were synthesized and tested for their in vitro antimicrobial activity against gram positive (Staphylococcus aureus ATCC 25923) and gram negative (Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853) bacteria as well as fungi (Candida albicans ATCC 10231, Candida tropicalis ATCC 13803 and Cryptococcus neoformans ATCC 90112). Compounds 6 were devoid of antibacterial as well as antifungal activities at maximum tested concentrations of 50 micrograms/ml for bacteria and 100 micrograms/ml for yeast.
SN - 0006-6648
UR - https://www.unboundmedicine.com/medline/citation/12064055/Synthesis_and_antimicrobial_evaluation_of_new_phenoxyacetamide_derivatives_
L2 - https://medlineplus.gov/molds.html
DB - PRIME
DP - Unbound Medicine
ER -